Dr. Georges-L.-Dumont University Hospital Centre is a Canadian hospital in Moncton, New Brunswick. Dr. Georges-L.-Dumont University Hospital Centre operates as a tertiary care referral hospital and specializes in oncology and trauma care services.

There are 423 beds in Dr.-Georges-L.-Dumont University Hospital Centre.

During the past decade, Dr.-Georges-L.-Dumont University Hospital Centre conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dr.-Georges-L.-Dumont University Hospital Centre" #1 sponsor was "Exactis Innovation" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Réseau de Santé Vitalité Health Network" with 2 trials sponsored and "Amsterdam UMC, location VUmc" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr.-Georges-L.-Dumont University Hospital Centre" #1 collaborator was "Baxter Healthcare Corporation" with 1 trials as a collaborator, "Canadian Blood Services" with 1 trials as a collaborator, "Cardiac Arrhythmia Network of Canada" with 1 trials as a collaborator, "Dutch Kidney Foundation" with 1 trials as a collaborator and "Exactis Innovation" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Dr.-Georges-L.-Dumont University Hospital Centre" are "Atrial Fibrillation" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Atrial Flutter" (1 trials) and "Breast Cancer Stage IV" (1 trials). Many other conditions were trialed in "Dr.-Georges-L.-Dumont University Hospital Centre" in a lesser frequency.

Most popular intervention types in "Dr.-Georges-L.-Dumont University Hospital Centre" are "Drug" (7 trials), "Other" (5 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "PF-02341066" (2 trials), "Abiraterone acetate or Enzalutamide or Docetaxel" (1 trials), "Atezolizumab" (1 trials) and "BI 1015550" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr.-Georges-L.-Dumont University Hospital Centre" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dr.-Georges-L.-Dumont University Hospital Centre". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Dr.-Georges-L.-Dumont University Hospital Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dr.-Georges-L.-Dumont University Hospital Centre, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".